Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Credit Suisse to hold a virtual conference » 04:55
11/11/21
11/11
04:55
11/11/21
04:55
USPH

U.S. Physical Therapy

$103.41 /

-0.59 (-0.57%)

, BAX

Baxter

$79.01 /

+1.31 (+1.69%)

, UTHR

United Therapeutics

$202.52 /

+3.57 (+1.79%)

, VRDN

Viridian Therapeutics

$18.51 /

+0.39 (+2.15%)

, ALXO

ALX Oncology

$42.35 /

+1.72 (+4.23%)

, CRSP

Crispr Therapeutics

$87.53 /

-3.71 (-4.07%)

, EHC

Encompass Health

$64.93 /

+0.89 (+1.39%)

, EFTR

eFfector Therapeutics

$10.22 /

-0.57 (-5.28%)

, CADL

Candel Therapeutics

$10.88 /

-0.02 (-0.18%)

, CBAY

CymaBay

$4.27 /

-0.02 (-0.47%)

, HSKA

Heska

$184.23 /

-3.555 (-1.89%)

, VYGR

Voyager Therapeutics

$3.53 /

-0.095 (-2.62%)

, CYT

Cyteir Therapeutics

$15.85 /

-0.295 (-1.83%)

, CYH

Community Health

$14.74 /

+0.04 (+0.27%)

30th Annual Virtual…

30th Annual Virtual Healthcare Conference to be held on November 8-11. Webcast Link

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$3.53 /

-0.095 (-2.62%)

VRDN Viridian Therapeutics
$18.51 /

+0.39 (+2.15%)

UTHR United Therapeutics
$202.52 /

+3.57 (+1.79%)

USPH U.S. Physical Therapy
$103.41 /

-0.59 (-0.57%)

HSKA Heska
$184.23 /

-3.555 (-1.89%)

EHC Encompass Health
$64.93 /

+0.89 (+1.39%)

EFTR eFfector Therapeutics
$10.22 /

-0.57 (-5.28%)

CYT Cyteir Therapeutics
$15.85 /

-0.295 (-1.83%)

CYH Community Health
$14.74 /

+0.04 (+0.27%)

CRSP Crispr Therapeutics
$87.53 /

-3.71 (-4.07%)

CBAY CymaBay
$4.27 /

-0.02 (-0.47%)

CADL Candel Therapeutics
$10.88 /

-0.02 (-0.18%)

BAX Baxter
$79.01 /

+1.31 (+1.69%)

ALXO ALX Oncology
$42.35 /

+1.72 (+4.23%)

USPH U.S. Physical Therapy
$103.41 /

-0.59 (-0.57%)

08/06/21 Barrington
U.S. Physical Therapy price target raised to $139 from $130 at Barrington
05/07/21 Barrington
U.S. Physical Therapy upgraded to Outperform from Market Perform at Barrington
05/03/21 Jefferies
U.S. Physical Therapy upgraded to Buy from Hold at Jefferies
02/26/21 Barrington
U.S. Physical Therapy downgraded to Market Perform from Outperform at Barrington
BAX Baxter
$79.01 /

+1.31 (+1.69%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
UTHR United Therapeutics
$202.52 /

+3.57 (+1.79%)

11/08/21 Needham
Liquidia Technologies price target raised to $8 from $5 at Needham
07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
VRDN Viridian Therapeutics
$18.51 /

+0.39 (+2.15%)

11/05/21 JMP Securities
Viridian Therapeutics price target lowered to $36 from $44 at JMP Securities
10/12/21 Evercore ISI
Evercore starts Viridian at Outperform on thyroid eye disease opportunity
10/12/21 Evercore ISI
Viridian Therapeutics initiated with an Outperform at Evercore ISI
01/25/21 Ladenburg
Viridian Therapeutics initiated with a Buy at Ladenburg
ALXO ALX Oncology
$42.35 /

+1.72 (+4.23%)

11/09/21 Piper Sandler
ALX Oncology price target lowered to $85 from $97 at Piper Sandler
11/09/21 H.C. Wainwright
H.C. Wainwright says ALX Oncology selloff on ASPEN-01 data an entry opportunity
11/04/21 Piper Sandler
ALX Oncology selloff after ASH abstract 'wholly misplaced,' says Piper Sandler
09/29/21 Stifel
ALX Oncology initiated with a Buy at Stifel
CRSP Crispr Therapeutics
$87.53 /

-3.71 (-4.07%)

11/08/21 Goldman Sachs
Bluebird Bio downgraded to Sell from Neutral at Goldman Sachs
11/04/21 Raymond James
ASH abstracts justify Crispr Therapeutics concerns, says Raymond James
11/04/21 Oppenheimer
Crispr Therapeutics price target lowered to $172 from $185 at Oppenheimer
10/19/21 SVB Leerink
Crispr Therapeutics initiated with an Outperform at SVB Leerink
EHC Encompass Health
$64.93 /

+0.89 (+1.39%)

11/03/21 Mizuho
Encompass Health price target lowered to $80 from $94 at Mizuho
11/01/21 BMO Capital
Encompass Health price target lowered to $75 from $102 at BMO Capital
10/29/21 Deutsche Bank
Encompass Health price target lowered to $95 from $110 at Deutsche Bank
10/13/21 Truist
Encompass Health price target lowered to $88 from $100 at Truist
EFTR eFfector Therapeutics
$10.22 /

-0.57 (-5.28%)

11/08/21 Stifel
eFfector Therapeutics upgraded to Buy at Stifel on NSCLC optimism
11/08/21 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
CADL Candel Therapeutics
$10.88 /

-0.02 (-0.18%)

08/23/21 UBS
Candel Therapeutics initiated with a Buy at UBS
08/23/21 Jefferies
Candel Therapeutics initiated with a Buy at Jefferies
08/23/21 Credit Suisse
Candel Therapeutics initiated with an Outperform at Credit Suisse
CBAY CymaBay
$4.27 /

-0.02 (-0.47%)

11/10/21 Piper Sandler
Piper Sandler says buyer of CymaBay at low valuation
08/18/21 B. Riley
CymaBay price target lowered to $10 from $13 at B. Riley
08/03/21 H.C. Wainwright
CymaBay price target lowered to $12 from $13 at H.C. Wainwright
08/02/21 Piper Sandler
CymaBay agreement removes 'key pressure point,' says Piper Sandler
HSKA Heska
$184.23 /

-3.555 (-1.89%)

10/26/21 Alliance Global Partners
Alliance Global reiterates Buy on Heska, says short report lacks credibility
08/04/21 Alliance Global Partners
Heska price target raised to $310 from $240 at Alliance Global Partners
08/04/21 Piper Sandler
Heska price target raised to $305 from $240 at Piper Sandler
07/12/21 Guggenheim
Heska upgraded to Buy from Neutral at Guggenheim
VYGR Voyager Therapeutics
$3.53 /

-0.095 (-2.62%)

11/02/21 Chardan
Voyager Therapeutics price target lowered to $4 from $5.50 at Chardan
10/07/21 Baird
Voyager Therapeutics upgraded to Outperform from Neutral at Baird
10/06/21 Wells Fargo
Voyager platform validated by Pfizer agreement, says Wells Fargo
09/20/21 Benchmark
Sale of Voyager more likely than out-licensing, says Benchmark
CYT Cyteir Therapeutics
$15.85 /

-0.295 (-1.83%)

07/13/21 JPMorgan
Cyteir Therapeutics initiated with an Overweight at JPMorgan
07/13/21 BofA
BofA starts Cyteir Therapeutics at Buy with $23 price target
07/13/21 Wedbush
Cyteir Therapeutics initiated with an Outperform at Wedbush
07/13/21 Morgan Stanley
Cyteir Therapeutics initiated with an Overweight at Morgan Stanley
CYH Community Health
$14.74 /

+0.04 (+0.27%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
VYGR Voyager Therapeutics
$3.53 /

-0.095 (-2.62%)

VRDN Viridian Therapeutics
$18.51 /

+0.39 (+2.15%)

UTHR United Therapeutics
$202.52 /

+3.57 (+1.79%)

USPH U.S. Physical Therapy
$103.41 /

-0.59 (-0.57%)

HSKA Heska
$184.23 /

-3.555 (-1.89%)

EHC Encompass Health
$64.93 /

+0.89 (+1.39%)

EFTR eFfector Therapeutics
$10.22 /

-0.57 (-5.28%)

CYH Community Health
$14.74 /

+0.04 (+0.27%)

CRSP Crispr Therapeutics
$87.53 /

-3.71 (-4.07%)

CBAY CymaBay
$4.27 /

-0.02 (-0.47%)

CADL Candel Therapeutics
$10.88 /

-0.02 (-0.18%)

BAX Baxter
$79.01 /

+1.31 (+1.69%)

ALXO ALX Oncology
$42.35 /

+1.72 (+4.23%)

  • 21
    Sep
  • 27
    Jul
  • 18
    Jun
  • 03
    Mar
  • 13
    Jan
  • 10
    Dec
HSKA Heska
$184.23 /

-3.555 (-1.89%)

CYH Community Health
$14.74 /

+0.04 (+0.27%)

BAX Baxter
$79.01 /

+1.31 (+1.69%)

VRDN Viridian Therapeutics
$18.51 /

+0.39 (+2.15%)

UTHR United Therapeutics
$202.52 /

+3.57 (+1.79%)

HSKA Heska
$184.23 /

-3.555 (-1.89%)

EHC Encompass Health
$64.93 /

+0.89 (+1.39%)

EFTR eFfector Therapeutics
$10.22 /

-0.57 (-5.28%)

CYT Cyteir Therapeutics
$15.85 /

-0.295 (-1.83%)

CYH Community Health
$14.74 /

+0.04 (+0.27%)

CRSP Crispr Therapeutics
$87.53 /

-3.71 (-4.07%)

CADL Candel Therapeutics
$10.88 /

-0.02 (-0.18%)

BAX Baxter
$79.01 /

+1.31 (+1.69%)

ALXO ALX Oncology
$42.35 /

+1.72 (+4.23%)

VYGR Voyager Therapeutics
$3.53 /

-0.095 (-2.62%)

VRDN Viridian Therapeutics
$18.51 /

+0.39 (+2.15%)

EHC Encompass Health
$64.93 /

+0.89 (+1.39%)

CYH Community Health
$14.74 /

+0.04 (+0.27%)

CRSP Crispr Therapeutics
$87.53 /

-3.71 (-4.07%)

BAX Baxter
$79.01 /

+1.31 (+1.69%)

Conference/Events
Credit Suisse to hold a virtual conference » 04:55
11/10/21
11/10
04:55
11/10/21
04:55
USPH

U.S. Physical Therapy

$103.83 /

-1.55 (-1.47%)

, BAX

Baxter

$77.70 /

-1.04 (-1.32%)

, UTHR

United Therapeutics

$198.97 /

-3.39 (-1.68%)

, VRDN

Viridian Therapeutics

$18.10 /

-0.53 (-2.84%)

, ALXO

ALX Oncology

$40.81 /

-11.615 (-22.16%)

, CRSP

Crispr Therapeutics

$91.26 /

-2.95 (-3.13%)

, EHC

Encompass Health

$64.05 /

-1.255 (-1.92%)

, EFTR

eFfector Therapeutics

$10.79 /

-0.32 (-2.88%)

, CADL

Candel Therapeutics

$10.95 /

-0.485 (-4.24%)

, CBAY

CymaBay

$4.30 /

+0.015 (+0.35%)

, HSKA

Heska

$188.94 /

-7.3 (-3.72%)

, VYGR

Voyager Therapeutics

$3.62 /

-0.02 (-0.55%)

, CYT

Cyteir Therapeutics

$16.14 /

-0.66 (-3.93%)

, CYH

Community Health

$14.70 /

+0.34 (+2.37%)

30th Annual Virtual…

30th Annual Virtual Healthcare Conference to be held on November 8-11. Webcast Link

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$3.62 /

-0.02 (-0.55%)

VRDN Viridian Therapeutics
$18.10 /

-0.53 (-2.84%)

UTHR United Therapeutics
$198.97 /

-3.39 (-1.68%)

USPH U.S. Physical Therapy
$103.83 /

-1.55 (-1.47%)

HSKA Heska
$188.94 /

-7.3 (-3.72%)

EHC Encompass Health
$64.05 /

-1.255 (-1.92%)

EFTR eFfector Therapeutics
$10.79 /

-0.32 (-2.88%)

CYT Cyteir Therapeutics
$16.14 /

-0.66 (-3.93%)

CYH Community Health
$14.70 /

+0.34 (+2.37%)

CRSP Crispr Therapeutics
$91.26 /

-2.95 (-3.13%)

CBAY CymaBay
$4.30 /

+0.015 (+0.35%)

CADL Candel Therapeutics
$10.95 /

-0.485 (-4.24%)

BAX Baxter
$77.70 /

-1.04 (-1.32%)

ALXO ALX Oncology
$40.81 /

-11.615 (-22.16%)

USPH U.S. Physical Therapy
$103.83 /

-1.55 (-1.47%)

08/06/21 Barrington
U.S. Physical Therapy price target raised to $139 from $130 at Barrington
05/07/21 Barrington
U.S. Physical Therapy upgraded to Outperform from Market Perform at Barrington
05/03/21 Jefferies
U.S. Physical Therapy upgraded to Buy from Hold at Jefferies
02/26/21 Barrington
U.S. Physical Therapy downgraded to Market Perform from Outperform at Barrington
BAX Baxter
$77.70 /

-1.04 (-1.32%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
UTHR United Therapeutics
$198.97 /

-3.39 (-1.68%)

11/08/21 Needham
Liquidia Technologies price target raised to $8 from $5 at Needham
07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
VRDN Viridian Therapeutics
$18.10 /

-0.53 (-2.84%)

11/05/21 JMP Securities
Viridian Therapeutics price target lowered to $36 from $44 at JMP Securities
10/12/21 Evercore ISI
Evercore starts Viridian at Outperform on thyroid eye disease opportunity
10/12/21 Evercore ISI
Viridian Therapeutics initiated with an Outperform at Evercore ISI
01/25/21 Ladenburg
Viridian Therapeutics initiated with a Buy at Ladenburg
ALXO ALX Oncology
$40.81 /

-11.615 (-22.16%)

11/09/21 Piper Sandler
ALX Oncology price target lowered to $85 from $97 at Piper Sandler
11/09/21 H.C. Wainwright
H.C. Wainwright says ALX Oncology selloff on ASPEN-01 data an entry opportunity
11/04/21 Piper Sandler
ALX Oncology selloff after ASH abstract 'wholly misplaced,' says Piper Sandler
09/29/21 Stifel
ALX Oncology initiated with a Buy at Stifel
CRSP Crispr Therapeutics
$91.26 /

-2.95 (-3.13%)

11/08/21 Goldman Sachs
Bluebird Bio downgraded to Sell from Neutral at Goldman Sachs
11/04/21 Raymond James
ASH abstracts justify Crispr Therapeutics concerns, says Raymond James
11/04/21 Oppenheimer
Crispr Therapeutics price target lowered to $172 from $185 at Oppenheimer
10/19/21 SVB Leerink
Crispr Therapeutics initiated with an Outperform at SVB Leerink
EHC Encompass Health
$64.05 /

-1.255 (-1.92%)

11/03/21 Mizuho
Encompass Health price target lowered to $80 from $94 at Mizuho
11/01/21 BMO Capital
Encompass Health price target lowered to $75 from $102 at BMO Capital
10/29/21 Deutsche Bank
Encompass Health price target lowered to $95 from $110 at Deutsche Bank
10/13/21 Truist
Encompass Health price target lowered to $88 from $100 at Truist
EFTR eFfector Therapeutics
$10.79 /

-0.32 (-2.88%)

11/08/21 Stifel
eFfector Therapeutics upgraded to Buy at Stifel on NSCLC optimism
11/08/21 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
CADL Candel Therapeutics
$10.95 /

-0.485 (-4.24%)

08/23/21 UBS
Candel Therapeutics initiated with a Buy at UBS
08/23/21 Jefferies
Candel Therapeutics initiated with a Buy at Jefferies
08/23/21 Credit Suisse
Candel Therapeutics initiated with an Outperform at Credit Suisse
CBAY CymaBay
$4.30 /

+0.015 (+0.35%)

08/18/21 B. Riley
CymaBay price target lowered to $10 from $13 at B. Riley
08/03/21 H.C. Wainwright
CymaBay price target lowered to $12 from $13 at H.C. Wainwright
08/02/21 Piper Sandler
CymaBay agreement removes 'key pressure point,' says Piper Sandler
06/21/21 Piper Sandler
Piper radar 'locked' on CymaBay EASL poster presentations on June 23
HSKA Heska
$188.94 /

-7.3 (-3.72%)

10/26/21 Alliance Global Partners
Alliance Global reiterates Buy on Heska, says short report lacks credibility
08/04/21 Alliance Global Partners
Heska price target raised to $310 from $240 at Alliance Global Partners
08/04/21 Piper Sandler
Heska price target raised to $305 from $240 at Piper Sandler
07/12/21 Guggenheim
Heska upgraded to Buy from Neutral at Guggenheim
VYGR Voyager Therapeutics
$3.62 /

-0.02 (-0.55%)

11/02/21 Chardan
Voyager Therapeutics price target lowered to $4 from $5.50 at Chardan
10/07/21 Baird
Voyager Therapeutics upgraded to Outperform from Neutral at Baird
10/06/21 Wells Fargo
Voyager platform validated by Pfizer agreement, says Wells Fargo
09/20/21 Benchmark
Sale of Voyager more likely than out-licensing, says Benchmark
CYT Cyteir Therapeutics
$16.14 /

-0.66 (-3.93%)

07/13/21 JPMorgan
Cyteir Therapeutics initiated with an Overweight at JPMorgan
07/13/21 BofA
BofA starts Cyteir Therapeutics at Buy with $23 price target
07/13/21 Wedbush
Cyteir Therapeutics initiated with an Outperform at Wedbush
07/13/21 Morgan Stanley
Cyteir Therapeutics initiated with an Overweight at Morgan Stanley
CYH Community Health
$14.70 /

+0.34 (+2.37%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
VYGR Voyager Therapeutics
$3.62 /

-0.02 (-0.55%)

VRDN Viridian Therapeutics
$18.10 /

-0.53 (-2.84%)

UTHR United Therapeutics
$198.97 /

-3.39 (-1.68%)

USPH U.S. Physical Therapy
$103.83 /

-1.55 (-1.47%)

HSKA Heska
$188.94 /

-7.3 (-3.72%)

EHC Encompass Health
$64.05 /

-1.255 (-1.92%)

EFTR eFfector Therapeutics
$10.79 /

-0.32 (-2.88%)

CYH Community Health
$14.70 /

+0.34 (+2.37%)

CRSP Crispr Therapeutics
$91.26 /

-2.95 (-3.13%)

CBAY CymaBay
$4.30 /

+0.015 (+0.35%)

CADL Candel Therapeutics
$10.95 /

-0.485 (-4.24%)

BAX Baxter
$77.70 /

-1.04 (-1.32%)

ALXO ALX Oncology
$40.81 /

-11.615 (-22.16%)

  • 21
    Sep
  • 27
    Jul
  • 18
    Jun
  • 03
    Mar
  • 13
    Jan
  • 10
    Dec
HSKA Heska
$188.94 /

-7.3 (-3.72%)

CYH Community Health
$14.70 /

+0.34 (+2.37%)

BAX Baxter
$77.70 /

-1.04 (-1.32%)

VRDN Viridian Therapeutics
$18.10 /

-0.53 (-2.84%)

UTHR United Therapeutics
$198.97 /

-3.39 (-1.68%)

HSKA Heska
$188.94 /

-7.3 (-3.72%)

EHC Encompass Health
$64.05 /

-1.255 (-1.92%)

EFTR eFfector Therapeutics
$10.79 /

-0.32 (-2.88%)

CYT Cyteir Therapeutics
$16.14 /

-0.66 (-3.93%)

CYH Community Health
$14.70 /

+0.34 (+2.37%)

CRSP Crispr Therapeutics
$91.26 /

-2.95 (-3.13%)

CADL Candel Therapeutics
$10.95 /

-0.485 (-4.24%)

BAX Baxter
$77.70 /

-1.04 (-1.32%)

ALXO ALX Oncology
$40.81 /

-11.615 (-22.16%)

VYGR Voyager Therapeutics
$3.62 /

-0.02 (-0.55%)

VRDN Viridian Therapeutics
$18.10 /

-0.53 (-2.84%)

EHC Encompass Health
$64.05 /

-1.255 (-1.92%)

CYH Community Health
$14.70 /

+0.34 (+2.37%)

CRSP Crispr Therapeutics
$91.26 /

-2.95 (-3.13%)

BAX Baxter
$77.70 /

-1.04 (-1.32%)

Conference/Events
Credit Suisse to hold a virtual conference » 04:55
11/09/21
11/09
04:55
11/09/21
04:55
USPH

U.S. Physical Therapy

$105.78 /

-3.63 (-3.32%)

, BAX

Baxter

$78.75 /

+0.72 (+0.92%)

, UTHR

United Therapeutics

$202.19 /

-0.18 (-0.09%)

, VRDN

Viridian Therapeutics

$18.50 /

-0.5 (-2.63%)

, ALXO

ALX Oncology

$52.16 /

+1.32 (+2.60%)

, CRSP

Crispr Therapeutics

$94.21 /

+3.9 (+4.32%)

, EHC

Encompass Health

$65.39 /

+0.445 (+0.69%)

, EFTR

eFfector Therapeutics

$11.06 /

+0.68 (+6.55%)

, CADL

Candel Therapeutics

$11.44 /

+0.725 (+6.77%)

, CBAY

CymaBay

$4.26 /

-0.13 (-2.96%)

, HSKA

Heska

$195.37 /

+3.035 (+1.58%)

, VYGR

Voyager Therapeutics

$3.64 /

-0.16 (-4.21%)

, CYT

Cyteir Therapeutics

$16.80 /

+0.05 (+0.30%)

, CYH

Community Health

$14.36 /

-0.04 (-0.28%)

30th Annual Virtual…

30th Annual Virtual Healthcare Conference to be held on November 8-11. Webcast Link

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$3.64 /

-0.16 (-4.21%)

VRDN Viridian Therapeutics
$18.50 /

-0.5 (-2.63%)

UTHR United Therapeutics
$202.19 /

-0.18 (-0.09%)

USPH U.S. Physical Therapy
$105.78 /

-3.63 (-3.32%)

HSKA Heska
$195.37 /

+3.035 (+1.58%)

EHC Encompass Health
$65.39 /

+0.445 (+0.69%)

EFTR eFfector Therapeutics
$11.06 /

+0.68 (+6.55%)

CYT Cyteir Therapeutics
$16.80 /

+0.05 (+0.30%)

CYH Community Health
$14.36 /

-0.04 (-0.28%)

CRSP Crispr Therapeutics
$94.21 /

+3.9 (+4.32%)

CBAY CymaBay
$4.26 /

-0.13 (-2.96%)

CADL Candel Therapeutics
$11.44 /

+0.725 (+6.77%)

BAX Baxter
$78.75 /

+0.72 (+0.92%)

ALXO ALX Oncology
$52.16 /

+1.32 (+2.60%)

USPH U.S. Physical Therapy
$105.78 /

-3.63 (-3.32%)

08/06/21 Barrington
U.S. Physical Therapy price target raised to $139 from $130 at Barrington
05/07/21 Barrington
U.S. Physical Therapy upgraded to Outperform from Market Perform at Barrington
05/03/21 Jefferies
U.S. Physical Therapy upgraded to Buy from Hold at Jefferies
02/26/21 Barrington
U.S. Physical Therapy downgraded to Market Perform from Outperform at Barrington
BAX Baxter
$78.75 /

+0.72 (+0.92%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
UTHR United Therapeutics
$202.19 /

-0.18 (-0.09%)

11/08/21 Needham
Liquidia Technologies price target raised to $8 from $5 at Needham
07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
VRDN Viridian Therapeutics
$18.50 /

-0.5 (-2.63%)

11/05/21 JMP Securities
Viridian Therapeutics price target lowered to $36 from $44 at JMP Securities
10/12/21 Evercore ISI
Evercore starts Viridian at Outperform on thyroid eye disease opportunity
10/12/21 Evercore ISI
Viridian Therapeutics initiated with an Outperform at Evercore ISI
01/25/21 Ladenburg
Viridian Therapeutics initiated with a Buy at Ladenburg
ALXO ALX Oncology
$52.16 /

+1.32 (+2.60%)

11/04/21 Piper Sandler
ALX Oncology selloff after ASH abstract 'wholly misplaced,' says Piper Sandler
09/29/21 Stifel
ALX Oncology initiated with a Buy at Stifel
07/05/21 Piper Sandler
ALX Oncology update for ALX148 'incrementally positive,' says Piper Sandler
05/04/21 Credit Suisse
ALX Oncology assumed with an Outperform at Credit Suisse
CRSP Crispr Therapeutics
$94.21 /

+3.9 (+4.32%)

11/08/21 Goldman Sachs
Bluebird Bio downgraded to Sell from Neutral at Goldman Sachs
11/04/21 Raymond James
ASH abstracts justify Crispr Therapeutics concerns, says Raymond James
11/04/21 Oppenheimer
Crispr Therapeutics price target lowered to $172 from $185 at Oppenheimer
10/19/21 SVB Leerink
Crispr Therapeutics initiated with an Outperform at SVB Leerink
EHC Encompass Health
$65.39 /

+0.445 (+0.69%)

11/03/21 Mizuho
Encompass Health price target lowered to $80 from $94 at Mizuho
11/01/21 BMO Capital
Encompass Health price target lowered to $75 from $102 at BMO Capital
10/29/21 Deutsche Bank
Encompass Health price target lowered to $95 from $110 at Deutsche Bank
10/13/21 Truist
Encompass Health price target lowered to $88 from $100 at Truist
EFTR eFfector Therapeutics
$11.06 /

+0.68 (+6.55%)

11/08/21 Stifel
eFfector Therapeutics upgraded to Buy at Stifel on NSCLC optimism
11/08/21 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
CADL Candel Therapeutics
$11.44 /

+0.725 (+6.77%)

08/23/21 UBS
Candel Therapeutics initiated with a Buy at UBS
08/23/21 Jefferies
Candel Therapeutics initiated with a Buy at Jefferies
08/23/21 Credit Suisse
Candel Therapeutics initiated with an Outperform at Credit Suisse
CBAY CymaBay
$4.26 /

-0.13 (-2.96%)

08/18/21 B. Riley
CymaBay price target lowered to $10 from $13 at B. Riley
08/03/21 H.C. Wainwright
CymaBay price target lowered to $12 from $13 at H.C. Wainwright
08/02/21 Piper Sandler
CymaBay agreement removes 'key pressure point,' says Piper Sandler
06/21/21 Piper Sandler
Piper radar 'locked' on CymaBay EASL poster presentations on June 23
HSKA Heska
$195.37 /

+3.035 (+1.58%)

10/26/21 Alliance Global Partners
Alliance Global reiterates Buy on Heska, says short report lacks credibility
08/04/21 Alliance Global Partners
Heska price target raised to $310 from $240 at Alliance Global Partners
08/04/21 Piper Sandler
Heska price target raised to $305 from $240 at Piper Sandler
07/12/21 Guggenheim
Heska upgraded to Buy from Neutral at Guggenheim
VYGR Voyager Therapeutics
$3.64 /

-0.16 (-4.21%)

11/02/21 Chardan
Voyager Therapeutics price target lowered to $4 from $5.50 at Chardan
10/07/21 Baird
Voyager Therapeutics upgraded to Outperform from Neutral at Baird
10/06/21 Wells Fargo
Voyager platform validated by Pfizer agreement, says Wells Fargo
09/20/21 Benchmark
Sale of Voyager more likely than out-licensing, says Benchmark
CYT Cyteir Therapeutics
$16.80 /

+0.05 (+0.30%)

07/13/21 JPMorgan
Cyteir Therapeutics initiated with an Overweight at JPMorgan
07/13/21 BofA
BofA starts Cyteir Therapeutics at Buy with $23 price target
07/13/21 Wedbush
Cyteir Therapeutics initiated with an Outperform at Wedbush
07/13/21 Morgan Stanley
Cyteir Therapeutics initiated with an Overweight at Morgan Stanley
CYH Community Health
$14.36 /

-0.04 (-0.28%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
VYGR Voyager Therapeutics
$3.64 /

-0.16 (-4.21%)

VRDN Viridian Therapeutics
$18.50 /

-0.5 (-2.63%)

UTHR United Therapeutics
$202.19 /

-0.18 (-0.09%)

USPH U.S. Physical Therapy
$105.78 /

-3.63 (-3.32%)

HSKA Heska
$195.37 /

+3.035 (+1.58%)

EHC Encompass Health
$65.39 /

+0.445 (+0.69%)

EFTR eFfector Therapeutics
$11.06 /

+0.68 (+6.55%)

CYH Community Health
$14.36 /

-0.04 (-0.28%)

CRSP Crispr Therapeutics
$94.21 /

+3.9 (+4.32%)

CBAY CymaBay
$4.26 /

-0.13 (-2.96%)

CADL Candel Therapeutics
$11.44 /

+0.725 (+6.77%)

BAX Baxter
$78.75 /

+0.72 (+0.92%)

ALXO ALX Oncology
$52.16 /

+1.32 (+2.60%)

  • 21
    Sep
  • 27
    Jul
  • 18
    Jun
  • 03
    Mar
  • 13
    Jan
  • 10
    Dec
HSKA Heska
$195.37 /

+3.035 (+1.58%)

CYH Community Health
$14.36 /

-0.04 (-0.28%)

BAX Baxter
$78.75 /

+0.72 (+0.92%)

VRDN Viridian Therapeutics
$18.50 /

-0.5 (-2.63%)

UTHR United Therapeutics
$202.19 /

-0.18 (-0.09%)

HSKA Heska
$195.37 /

+3.035 (+1.58%)

EHC Encompass Health
$65.39 /

+0.445 (+0.69%)

EFTR eFfector Therapeutics
$11.06 /

+0.68 (+6.55%)

CYT Cyteir Therapeutics
$16.80 /

+0.05 (+0.30%)

CYH Community Health
$14.36 /

-0.04 (-0.28%)

CRSP Crispr Therapeutics
$94.21 /

+3.9 (+4.32%)

CADL Candel Therapeutics
$11.44 /

+0.725 (+6.77%)

BAX Baxter
$78.75 /

+0.72 (+0.92%)

ALXO ALX Oncology
$52.16 /

+1.32 (+2.60%)

VYGR Voyager Therapeutics
$3.64 /

-0.16 (-4.21%)

VRDN Viridian Therapeutics
$18.50 /

-0.5 (-2.63%)

EHC Encompass Health
$65.39 /

+0.445 (+0.69%)

CYH Community Health
$14.36 /

-0.04 (-0.28%)

CRSP Crispr Therapeutics
$94.21 /

+3.9 (+4.32%)

BAX Baxter
$78.75 /

+0.72 (+0.92%)

Conference/Events
Credit Suisse to hold a virtual conference » 10:59
11/08/21
11/08
10:59
11/08/21
10:59
USPH

U.S. Physical Therapy

$109.36 /

-0.05 (-0.05%)

, BAX

Baxter

$78.84 /

+0.81 (+1.04%)

, UTHR

United Therapeutics

$200.75 /

-1.62 (-0.80%)

, VRDN

Viridian Therapeutics

$18.12 /

-0.88 (-4.63%)

, ALXO

ALX Oncology

$55.06 /

+4.22 (+8.30%)

, CRSP

Crispr Therapeutics

$94.11 /

+3.8 (+4.21%)

, EHC

Encompass Health

$65.05 /

+0.105 (+0.16%)

, EFTR

eFfector Therapeutics

$10.98 /

+0.6 (+5.78%)

, CADL

Candel Therapeutics

$11.48 /

+0.77 (+7.19%)

, CBAY

CymaBay

$4.31 /

-0.08 (-1.82%)

, HSKA

Heska

$197.45 /

+5.115 (+2.66%)

, VYGR

Voyager Therapeutics

$3.72 /

-0.08 (-2.11%)

, CYT

Cyteir Therapeutics

$17.14 /

+0.39 (+2.33%)

, CYH

Community Health

$14.55 /

+0.15 (+1.04%)

30th Annual Virtual…

30th Annual Virtual Healthcare Conference to be held on November 8-11. Webcast Link

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$3.72 /

-0.08 (-2.11%)

VRDN Viridian Therapeutics
$18.12 /

-0.88 (-4.63%)

UTHR United Therapeutics
$200.75 /

-1.62 (-0.80%)

USPH U.S. Physical Therapy
$109.36 /

-0.05 (-0.05%)

HSKA Heska
$197.45 /

+5.115 (+2.66%)

EHC Encompass Health
$65.05 /

+0.105 (+0.16%)

EFTR eFfector Therapeutics
$10.98 /

+0.6 (+5.78%)

CYT Cyteir Therapeutics
$17.14 /

+0.39 (+2.33%)

CYH Community Health
$14.55 /

+0.15 (+1.04%)

CRSP Crispr Therapeutics
$94.11 /

+3.8 (+4.21%)

CBAY CymaBay
$4.31 /

-0.08 (-1.82%)

CADL Candel Therapeutics
$11.48 /

+0.77 (+7.19%)

BAX Baxter
$78.84 /

+0.81 (+1.04%)

ALXO ALX Oncology
$55.06 /

+4.22 (+8.30%)

USPH U.S. Physical Therapy
$109.36 /

-0.05 (-0.05%)

08/06/21 Barrington
U.S. Physical Therapy price target raised to $139 from $130 at Barrington
05/07/21 Barrington
U.S. Physical Therapy upgraded to Outperform from Market Perform at Barrington
05/03/21 Jefferies
U.S. Physical Therapy upgraded to Buy from Hold at Jefferies
02/26/21 Barrington
U.S. Physical Therapy downgraded to Market Perform from Outperform at Barrington
BAX Baxter
$78.84 /

+0.81 (+1.04%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
UTHR United Therapeutics
$200.75 /

-1.62 (-0.80%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
VRDN Viridian Therapeutics
$18.12 /

-0.88 (-4.63%)

11/05/21 JMP Securities
Viridian Therapeutics price target lowered to $36 from $44 at JMP Securities
10/12/21 Evercore ISI
Evercore starts Viridian at Outperform on thyroid eye disease opportunity
10/12/21 Evercore ISI
Viridian Therapeutics initiated with an Outperform at Evercore ISI
01/25/21 Ladenburg
Viridian Therapeutics initiated with a Buy at Ladenburg
ALXO ALX Oncology
$55.06 /

+4.22 (+8.30%)

11/04/21 Piper Sandler
ALX Oncology selloff after ASH abstract 'wholly misplaced,' says Piper Sandler
09/29/21 Stifel
ALX Oncology initiated with a Buy at Stifel
07/05/21 Piper Sandler
ALX Oncology update for ALX148 'incrementally positive,' says Piper Sandler
05/04/21 Credit Suisse
ALX Oncology assumed with an Outperform at Credit Suisse
CRSP Crispr Therapeutics
$94.11 /

+3.8 (+4.21%)

11/08/21 Goldman Sachs
Bluebird Bio downgraded to Sell from Neutral at Goldman Sachs
11/04/21 Raymond James
ASH abstracts justify Crispr Therapeutics concerns, says Raymond James
11/04/21 Oppenheimer
Crispr Therapeutics price target lowered to $172 from $185 at Oppenheimer
10/19/21 SVB Leerink
Crispr Therapeutics initiated with an Outperform at SVB Leerink
EHC Encompass Health
$65.05 /

+0.105 (+0.16%)

11/03/21 Mizuho
Encompass Health price target lowered to $80 from $94 at Mizuho
11/01/21 BMO Capital
Encompass Health price target lowered to $75 from $102 at BMO Capital
10/29/21 Deutsche Bank
Encompass Health price target lowered to $95 from $110 at Deutsche Bank
10/13/21 Truist
Encompass Health price target lowered to $88 from $100 at Truist
EFTR eFfector Therapeutics
$10.98 /

+0.6 (+5.78%)

10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
09/21/21 JMP Securities
eFfector Therapeutics initiated with an Outperform at JMP Securities
09/20/21 Stifel
eFfector Therapeutics initiated with a Hold at Stifel
CADL Candel Therapeutics
$11.48 /

+0.77 (+7.19%)

08/23/21 UBS
Candel Therapeutics initiated with a Buy at UBS
08/23/21 Jefferies
Candel Therapeutics initiated with a Buy at Jefferies
08/23/21 Credit Suisse
Candel Therapeutics initiated with an Outperform at Credit Suisse
CBAY CymaBay
$4.31 /

-0.08 (-1.82%)

08/18/21 B. Riley
CymaBay price target lowered to $10 from $13 at B. Riley
08/03/21 H.C. Wainwright
CymaBay price target lowered to $12 from $13 at H.C. Wainwright
08/02/21 Piper Sandler
CymaBay agreement removes 'key pressure point,' says Piper Sandler
06/21/21 Piper Sandler
Piper radar 'locked' on CymaBay EASL poster presentations on June 23
HSKA Heska
$197.45 /

+5.115 (+2.66%)

10/26/21 Alliance Global Partners
Alliance Global reiterates Buy on Heska, says short report lacks credibility
08/04/21 Alliance Global Partners
Heska price target raised to $310 from $240 at Alliance Global Partners
08/04/21 Piper Sandler
Heska price target raised to $305 from $240 at Piper Sandler
07/12/21 Guggenheim
Heska upgraded to Buy from Neutral at Guggenheim
VYGR Voyager Therapeutics
$3.72 /

-0.08 (-2.11%)

11/02/21 Chardan
Voyager Therapeutics price target lowered to $4 from $5.50 at Chardan
10/07/21 Baird
Voyager Therapeutics upgraded to Outperform from Neutral at Baird
10/06/21 Wells Fargo
Voyager platform validated by Pfizer agreement, says Wells Fargo
09/20/21 Benchmark
Sale of Voyager more likely than out-licensing, says Benchmark
CYT Cyteir Therapeutics
$17.14 /

+0.39 (+2.33%)

07/13/21 JPMorgan
Cyteir Therapeutics initiated with an Overweight at JPMorgan
07/13/21 BofA
BofA starts Cyteir Therapeutics at Buy with $23 price target
07/13/21 Wedbush
Cyteir Therapeutics initiated with an Outperform at Wedbush
07/13/21 Morgan Stanley
Cyteir Therapeutics initiated with an Overweight at Morgan Stanley
CYH Community Health
$14.55 /

+0.15 (+1.04%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
VYGR Voyager Therapeutics
$3.72 /

-0.08 (-2.11%)

VRDN Viridian Therapeutics
$18.12 /

-0.88 (-4.63%)

UTHR United Therapeutics
$200.75 /

-1.62 (-0.80%)

USPH U.S. Physical Therapy
$109.36 /

-0.05 (-0.05%)

HSKA Heska
$197.45 /

+5.115 (+2.66%)

EHC Encompass Health
$65.05 /

+0.105 (+0.16%)

EFTR eFfector Therapeutics
$10.98 /

+0.6 (+5.78%)

CYH Community Health
$14.55 /

+0.15 (+1.04%)

CRSP Crispr Therapeutics
$94.11 /

+3.8 (+4.21%)

CBAY CymaBay
$4.31 /

-0.08 (-1.82%)

CADL Candel Therapeutics
$11.48 /

+0.77 (+7.19%)

BAX Baxter
$78.84 /

+0.81 (+1.04%)

ALXO ALX Oncology
$55.06 /

+4.22 (+8.30%)

  • 21
    Sep
  • 27
    Jul
  • 18
    Jun
  • 03
    Mar
  • 13
    Jan
  • 10
    Dec
HSKA Heska
$197.45 /

+5.115 (+2.66%)

CYH Community Health
$14.55 /

+0.15 (+1.04%)

BAX Baxter
$78.84 /

+0.81 (+1.04%)

VRDN Viridian Therapeutics
$18.12 /

-0.88 (-4.63%)

UTHR United Therapeutics
$200.75 /

-1.62 (-0.80%)

HSKA Heska
$197.45 /

+5.115 (+2.66%)

EHC Encompass Health
$65.05 /

+0.105 (+0.16%)

EFTR eFfector Therapeutics
$10.98 /

+0.6 (+5.78%)

CYT Cyteir Therapeutics
$17.14 /

+0.39 (+2.33%)

CYH Community Health
$14.55 /

+0.15 (+1.04%)

CRSP Crispr Therapeutics
$94.11 /

+3.8 (+4.21%)

CADL Candel Therapeutics
$11.48 /

+0.77 (+7.19%)

BAX Baxter
$78.84 /

+0.81 (+1.04%)

ALXO ALX Oncology
$55.06 /

+4.22 (+8.30%)

VYGR Voyager Therapeutics
$3.72 /

-0.08 (-2.11%)

VRDN Viridian Therapeutics
$18.12 /

-0.88 (-4.63%)

EHC Encompass Health
$65.05 /

+0.105 (+0.16%)

CYH Community Health
$14.55 /

+0.15 (+1.04%)

CRSP Crispr Therapeutics
$94.11 /

+3.8 (+4.21%)

BAX Baxter
$78.84 /

+0.81 (+1.04%)

Over a month ago
Hot Stocks
Community Health rises 15.3% » 09:47
10/28/21
10/28
09:47
10/28/21
09:47
CYH

Community Health

$11.54 /

+1.44 (+14.26%)

Community Health is up…

Community Health is up 15.3%, or $1.55 to $11.66.

ShowHide Related Items >><<
CYH Community Health
$11.54 /

+1.44 (+14.26%)

CYH Community Health
$11.54 /

+1.44 (+14.26%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
CYH Community Health
$11.54 /

+1.44 (+14.26%)

CYH Community Health
$11.54 /

+1.44 (+14.26%)

CYH Community Health
$11.54 /

+1.44 (+14.26%)

CYH Community Health
$11.54 /

+1.44 (+14.26%)

On The Fly
Fly Intel: After-Hours Movers » 18:49
10/27/21
10/27
18:49
10/27/21
18:49
LC

LendingClub

$31.54 /

-3.18 (-9.16%)

, WOLF

Wolfspeed

$90.89 /

-2.6 (-2.78%)

, F

Ford

$15.52 /

-0.435 (-2.73%)

, ALGN

Align Technology

$606.11 /

+13.7 (+2.31%)

, CYH

Community Health

$10.11 /

+0.07 (+0.70%)

, SCI

Service Corp.

$63.41 /

-0.6 (-0.94%)

, KLAC

KLA Corp.

$341.17 /

-0.985 (-0.29%)

, BCOV

Brightcove

$11.87 /

-0.27 (-2.22%)

, TWLO

Twilio

$346.09 /

-7.845 (-2.22%)

, FLS

Flowserve

$36.04 /

-1.01 (-2.73%)

, ORN

Orion Group

$4.55 /

-0.11 (-2.36%)

, FLEX

Flex

$18.31 /

-0.41 (-2.19%)

, RBBN

Ribbon Communications

$5.86 /

-0.13 (-2.17%)

, JAKK

JAKKS Pacific

$12.05 /

+0.34 (+2.90%)

, EBAY

eBay

$77.68 /

-0.83 (-1.06%)

, ZVO

Zovio

$2.26 /

-0.01 (-0.44%)

, TDOC

Teladoc

$138.38 /

-2.98 (-2.11%)

, NOW

ServiceNow

$664.99 /

-11.99 (-1.77%)

, EW

Edwards Lifesciences

$116.09 /

-0.975 (-0.83%)

, NTGR

Netgear

$31.42 /

-0.21 (-0.66%)

Check out this evening's…

ShowHide Related Items >><<
ZVO Zovio
$2.26 /

-0.01 (-0.44%)

WOLF Wolfspeed
$90.89 /

-2.6 (-2.78%)

TWLO Twilio
$346.09 /

-7.845 (-2.22%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

SCI Service Corp.
$63.41 /

-0.6 (-0.94%)

RBBN Ribbon Communications
$5.86 /

-0.13 (-2.17%)

ORN Orion Group
$4.55 /

-0.11 (-2.36%)

NTGR Netgear
$31.42 /

-0.21 (-0.66%)

NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

LC LendingClub
$31.54 /

-3.18 (-9.16%)

KLAC KLA Corp.
$341.17 /

-0.985 (-0.29%)

JAKK JAKKS Pacific
$12.05 /

+0.34 (+2.90%)

FLEX Flex
$18.31 /

-0.41 (-2.19%)

F Ford
$15.52 /

-0.435 (-2.73%)

EW Edwards Lifesciences
$116.09 /

-0.975 (-0.83%)

EBAY eBay
$77.68 /

-0.83 (-1.06%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

BCOV Brightcove
$11.87 /

-0.27 (-2.22%)

ALGN Align Technology
$606.11 /

+13.7 (+2.31%)

LC LendingClub
$31.54 /

-3.18 (-9.16%)

08/20/21
Fly Intel: Top five analyst upgrades
08/20/21 Maxim
LendingClub upgraded to Buy from Hold at Maxim
08/20/21 Maxim
LendingClub upgraded to Buy from Hold at Maxim
07/29/21 Wedbush
LendingClub price target raised to $33.50 from $25 at Wedbush
WOLF Wolfspeed
$90.89 /

-2.6 (-2.78%)

09/27/21 Deutsche Bank
Cree price target lowered to $90 from $100 at Deutsche Bank
F Ford
$15.52 /

-0.435 (-2.73%)

10/27/21 Wedbush
Other bulk deals to follow and further benefit Tesla, says Wedbush
10/25/21 Wedbush
Hertz mega deal another 'feather in the cap' for Tesla, says Wedbush
10/25/21 Deutsche Bank
Ford price target raised to $18 from $16 at Deutsche Bank
10/22/21 Barclays
Barclays 'not panicking' on Ford shares despite higher aluminum prices
ALGN Align Technology
$606.11 /

+13.7 (+2.31%)

10/18/21 Piper Sandler
Align Technology pullback brings attractive opportunity, says Piper Sandler
10/13/21 Stifel
Stifel says 'soft' checks support below-consensus estimates for Align Technology
09/30/21 Credit Suisse
Align Technology assumed with an Outperform at Credit Suisse
09/02/21 Stifel
Stifel ups Patterson Companies target to $32 following quarterly results
CYH Community Health
$10.11 /

+0.07 (+0.70%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
SCI Service Corp.
$63.41 /

-0.6 (-0.94%)

05/10/21 Oppenheimer
Service Corp. price target raised to $59 from $54 at Oppenheimer
11/02/20 Credit Suisse
Service Corp. price target raised to $55 from $50 at Credit Suisse
KLAC KLA Corp.
$341.17 /

-0.985 (-0.29%)

10/15/21 KGI Securities
KLA Corp. upgraded to Outperform from Neutral at KGI Securities
10/14/21 Piper Sandler
Piper starts KLA at Neutral on limited share upside potential
10/14/21 Piper Sandler
KLA Corp. initiated with a Neutral at Piper Sandler
09/17/21 BofA
KLA Corp. price target raised to $450 from $425 at BofA
BCOV Brightcove
$11.87 /

-0.27 (-2.22%)

07/29/21 Northland
Brightcove price target lowered to $23 from $29 at Northland
07/29/21 Lake Street
Brightcove price target lowered to $17 from $25 at Lake Street
02/18/21 Lake Street
Brightcove price target raised to $27 from $20 at Lake Street
01/29/21 B. Riley
Brightcove transferred with Buy, $22 target at B. Riley Securities
TWLO Twilio
$346.09 /

-7.845 (-2.22%)

10/20/21 Barclays
Twilio initiated with an Equal Weight at Barclays
09/30/21 Piper Sandler
Twilio risk/reward has turned 'compelling,' says Piper Sandler
09/16/21 Summit Insights
Twilio assumed with a Buy at Summit Insights
07/30/21 Baird
Twilio price target raised to $450 from $430 at Baird
FLS Flowserve
$36.04 /

-1.01 (-2.73%)

10/14/21 UBS
Flowserve upgraded to Buy at UBS on 'underappreciated' earnings growth
10/14/21 UBS
Flowserve upgraded to Buy from Neutral at UBS
07/08/21
Fly Intel: Top five analyst upgrades
07/08/21 Credit Suisse
Flowserve upgraded to Outperform from Neutral at Credit Suisse
ORN Orion Group
$4.55 /

-0.11 (-2.36%)

10/01/21 B. Riley
Orion Group price target lowered to $4.50 from $5.50 at B. Riley
07/30/21
Fly Intel: Top five analyst downgrades
07/30/21 B. Riley
Orion Group downgraded on 'muted' backlog growth at B. Riley
07/30/21 B. Riley
Orion Group downgraded to Neutral from Buy at B. Riley
FLEX Flex
$18.31 /

-0.41 (-2.19%)

05/25/21 Stifel
Plexus warning may be signal that supply constraints will worsen, says Stifel
05/07/21 Citi
Flex price target raised to $25 from $22 at Citi
05/06/21 Cross Research
Cross Research upgrades Flex to Buy after 'strong' Q4
05/06/21 Cross Research
Flex upgraded to Buy from Hold at Cross Research
RBBN Ribbon Communications
$5.86 /

-0.13 (-2.17%)

07/29/21 B. Riley
Ribbon Communications price target lowered to $11.50 from $13.50 at B. Riley
04/08/21 Northland
Ribbon could see 'healthy return' on Kandy if AVC sold, says Northland
03/25/21 B. Riley
Ribbon Communications pullback a buying opportunity, says B. Riley
02/18/21 B. Riley
Ribbon Communications price target raised to $14 from $12 at B. Riley
JAKK JAKKS Pacific
$12.05 /

+0.34 (+2.90%)

07/23/21 BMO Capital
BMO 'increasingly more concerned' about guidance from toy companies
EBAY eBay
$77.68 /

-0.83 (-1.06%)

10/25/21 Truist
eBay price target raised to $75 from $66 at Truist
10/25/21 Wedbush
eBay price target raised to $74 from $63 at Wedbush
10/22/21 BMO Capital
eBay price target raised to $71 from $63 at BMO Capital
09/27/21 Baird
eBay price target raised to $80 from $70 at Baird
ZVO Zovio
$2.26 /

-0.01 (-0.44%)

05/13/21 Barrington
Zovio price target lowered to $5 from $10 at Barrington
04/09/21
Fly Intel: Top five analyst initiations
04/09/21 Northland
Zovio initiated with an Outperform at Northland
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

10/18/21 Wells Fargo
Wells Fargo starts telehealth 'one-stop shop' Teladoc at Overweight
09/20/21 KeyBanc
New CEO 'certainly a positive surprise' for NextGen shareholders, says KeyBanc
09/15/21 RBC Capital
Teladoc long-term growth outlook intact, says RBC Capital
08/09/21 Cowen
Teladoc price target lowered to $188 from $240 at Cowen
NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

10/22/21 Oppenheimer
ServiceNow price target raised to $775 from $700 at Oppenheimer
10/20/21 BofA
ServiceNow price target raised to $800 from $700 at BofA
10/18/21 Mizuho
ServiceNow price target raised to $680 from $650 at Mizuho
10/11/21 JMP Securities
ServiceNow price target raised to $705 from $639 at JMP Securities
EW Edwards Lifesciences
$116.09 /

-0.975 (-0.83%)

09/21/21 Raymond James
Opsens price target raised to C$6.00 from C$2.75 at Raymond James
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
07/30/21 Canaccord
Edwards Lifesciences price target raised to $124 from $103 at Canaccord
07/30/21 Jefferies
Edwards Lifesciences price target raised to $130 from $110 at Jefferies
NTGR Netgear
$31.42 /

-0.21 (-0.66%)

07/22/21 BWS Financial
Netgear price target lowered to $43 from $54 at BWS Financial
07/22/21 Raymond James
Netgear price target lowered to $42 from $48 at Raymond James
07/22/21 Deutsche Bank
Netgear price target lowered to $34 from $44 at Deutsche Bank
02/04/21 BWS Financial
Netgear price target raised to $58 from $45 at BWS Financial
ZVO Zovio
$2.26 /

-0.01 (-0.44%)

WOLF Wolfspeed
$90.89 /

-2.6 (-2.78%)

TWLO Twilio
$346.09 /

-7.845 (-2.22%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

SCI Service Corp.
$63.41 /

-0.6 (-0.94%)

RBBN Ribbon Communications
$5.86 /

-0.13 (-2.17%)

ORN Orion Group
$4.55 /

-0.11 (-2.36%)

NTGR Netgear
$31.42 /

-0.21 (-0.66%)

NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

LC LendingClub
$31.54 /

-3.18 (-9.16%)

KLAC KLA Corp.
$341.17 /

-0.985 (-0.29%)

JAKK JAKKS Pacific
$12.05 /

+0.34 (+2.90%)

FLS Flowserve
$36.04 /

-1.01 (-2.73%)

FLEX Flex
$18.31 /

-0.41 (-2.19%)

F Ford
$15.52 /

-0.435 (-2.73%)

EW Edwards Lifesciences
$116.09 /

-0.975 (-0.83%)

EBAY eBay
$77.68 /

-0.83 (-1.06%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

BCOV Brightcove
$11.87 /

-0.27 (-2.22%)

ALGN Align Technology
$606.11 /

+13.7 (+2.31%)

  • 19
    Feb
TWLO Twilio
$346.09 /

-7.845 (-2.22%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

F Ford
$15.52 /

-0.435 (-2.73%)

EBAY eBay
$77.68 /

-0.83 (-1.06%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

ALGN Align Technology
$606.11 /

+13.7 (+2.31%)

ZVO Zovio
$2.26 /

-0.01 (-0.44%)

TWLO Twilio
$346.09 /

-7.845 (-2.22%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

SCI Service Corp.
$63.41 /

-0.6 (-0.94%)

ORN Orion Group
$4.55 /

-0.11 (-2.36%)

NTGR Netgear
$31.42 /

-0.21 (-0.66%)

NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

LC LendingClub
$31.54 /

-3.18 (-9.16%)

KLAC KLA Corp.
$341.17 /

-0.985 (-0.29%)

F Ford
$15.52 /

-0.435 (-2.73%)

EBAY eBay
$77.68 /

-0.83 (-1.06%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

BCOV Brightcove
$11.87 /

-0.27 (-2.22%)

ALGN Align Technology
$606.11 /

+13.7 (+2.31%)

WOLF Wolfspeed
$90.89 /

-2.6 (-2.78%)

TWLO Twilio
$346.09 /

-7.845 (-2.22%)

TDOC Teladoc
$138.38 /

-2.98 (-2.11%)

NOW ServiceNow
$664.99 /

-11.99 (-1.77%)

LC LendingClub
$31.54 /

-3.18 (-9.16%)

KLAC KLA Corp.
$341.17 /

-0.985 (-0.29%)

F Ford
$15.52 /

-0.435 (-2.73%)

EW Edwards Lifesciences
$116.09 /

-0.975 (-0.83%)

EBAY eBay
$77.68 /

-0.83 (-1.06%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

ALGN Align Technology
$606.11 /

+13.7 (+2.31%)

LC LendingClub
$31.54 /

-3.18 (-9.16%)

Earnings
Community Health reports Q3 EPS ex-items 69c, consensus 12c » 16:24
10/27/21
10/27
16:24
10/27/21
16:24
CYH

Community Health

$10.11 /

+0.07 (+0.70%)

Reports Q3 revenue…

Reports Q3 revenue $3.115B, consensus $3.02B. Adjusted EBITDA was $482M. On a same-store basis, admissions increased 2.8% and adjusted admissions increased 4.7%, compared with the same period in 2020. The company said, "During the third quarter, we experienced the largest number of COVID-19 cases to date. We are grateful to our medical staffs, clinical support teams and hospital leaders who again ensured exceptional care for their patients during this latest surge. We are also pleased with our results this quarter, especially as we balanced the demands of caring for COVID-19 patients while remaining focused on our growth strategies, key investments and operational improvement plans, which we believe will continue to drive positive results in the future."

ShowHide Related Items >><<
CYH Community Health
$10.11 /

+0.07 (+0.70%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
CYH Community Health
$10.11 /

+0.07 (+0.70%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

CYH Community Health
$10.11 /

+0.07 (+0.70%)

Options
Community Health options imply 10.2% move in share price post-earnings » 14:19
10/27/21
10/27
14:19
10/27/21
14:19
CYH

Community Health

$10.21 /

+0.17 (+1.69%)

Pre-earnings options…

Pre-earnings options volume in Community Health is normal with calls leading puts 19:3. Implied volatility suggests the market is anticipating a move near 10.2%, or $1.05, after results are released. Median move over the past eight quarters is 9.0%.

ShowHide Related Items >><<
CYH Community Health
$10.21 /

+0.17 (+1.69%)

CYH Community Health
$10.21 /

+0.17 (+1.69%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
CYH Community Health
$10.21 /

+0.17 (+1.69%)

CYH Community Health
$10.21 /

+0.17 (+1.69%)

CYH Community Health
$10.21 /

+0.17 (+1.69%)

CYH Community Health
$10.21 /

+0.17 (+1.69%)

Options
Upside call buy likely replaces expiring position in Community Health » 11:26
10/15/21
10/15
11:26
10/15/21
11:26
CYH

Community Health

$10.41 /

+0.21 (+2.06%)

Upside call buy likely…

Upside call buy likely replaces expiring position in Community Health Systems. Shares up 17c, or 1.6%, this morning near $10.37 with a notable trade on the Amex where a buyer paid 25c for 1500 Nov 13 calls to open a new position. Likely replaces 1500 Oct 13 calls that are set to expire later today. Those Oct 13 calls were opened on Sep expiration with shares nearly $1 higher. Earnings Oct 27th.

ShowHide Related Items >><<
CYH Community Health
$10.41 /

+0.21 (+2.06%)

CYH Community Health
$10.41 /

+0.21 (+2.06%)

10/13/21 Truist
Community Health price target lowered to $12 from $14 at Truist
09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
CYH Community Health
$10.41 /

+0.21 (+2.06%)

CYH Community Health
$10.41 /

+0.21 (+2.06%)

CYH Community Health
$10.41 /

+0.21 (+2.06%)

CYH Community Health
$10.41 /

+0.21 (+2.06%)

Recommendations
Community Health price target lowered to $12 from $14 at Truist » 09:23
10/13/21
10/13
09:23
10/13/21
09:23
CYH

Community Health

$10.22 /

-0.13 (-1.26%)

Truist analyst David…

Truist analyst David MacDonald lowered the firm's price target on Community Health to $12 from $14 and keeps a Hold rating on the shares as part of a broader research note on on the Healthcare Services sector. The analyst remains "broadly bullish" on the group with some "attractive areas of opportunity", but he also warns that the ongoing labor pressures could last into 2022 while the potential impact of sequestration also adds some risk.

ShowHide Related Items >><<
CYH Community Health
$10.22 /

-0.13 (-1.26%)

CYH Community Health
$10.22 /

-0.13 (-1.26%)

09/23/21 UBS
Community Health initiated with a Neutral at UBS
09/23/21 UBS
Community Health initiated with a Neutral at UBS
08/23/21 Truist
Community Health price target lowered to $14 from $17 at Truist
08/03/21 Barclays
Community Health price target raised to $10 from $6 at Barclays
CYH Community Health
$10.22 /

-0.13 (-1.26%)

CYH Community Health
$10.22 /

-0.13 (-1.26%)

CYH Community Health
$10.22 /

-0.13 (-1.26%)

CYH Community Health
$10.22 /

-0.13 (-1.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.